跳至主要内容
临床试验/ACTRN12619000269134
ACTRN12619000269134尚未招募1 期

Evaluation of the topical application of High-Density Lipoproteins on wound healing in patients with Diabetic Foot Ulcers

niversity of Adelaide0 个研究点目标入组 142 人开始时间: 2019年2月21日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
142

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Consenting men and non-pregnant women with diabetes (Type I and II), HbA1c<12%, eGFR >15 mL/min/1.73m2 and not on dialysis. Recent ray amputation (24-48 h) with no signs of active infection and evidence of adequate perfusion (>40 mm/Hg toe cuff pressure). Lipid drugs (e.g. statins, ezetimibe) are allowed.

排除标准

  • Elevated liver enzymes (>50 units AST, >56 units ALT), stroke or transient ischaemic attack within 3 months, heart failure, cancer with ongoing treatment or prognosis of <5 years, active inflammation, history of pancreatitis, DVT or pulmonary embolism, organ transplant, steroid therapy, hyperbaric treatment, dialysis, wound vacuum therapy, no history of Parkinson’s disease. Not deemed likely to require major leg amputation within 4 weeks or any obstacle to regular follow-up

研究者

发起方
niversity of Adelaide

相似试验